Diversified Trust’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$295K Buy
+17,060
New +$234K ﹤0.01% 915
2022
Q2
Sell
-18,210
Closed -$76K 749
2022
Q1
$76K Sell
18,210
-5,209
-22% -$23.1K ﹤0.01% 781
2021
Q4
$112K Hold
23,419
﹤0.01% 802
2021
Q3
$125K Sell
23,419
-13,485
-37% -$67.9K ﹤0.01% 755
2021
Q2
$189K Buy
36,904
+16,168
+78% +$91.9K 0.01% 716
2021
Q1
$140K Buy
+20,736
New +$115K 0.01% 715

Other funds holding AMRX

Diversified Trust's AMRX Position: Q2 2026 in Review

Diversified Trust opened a new position in Amneal Pharmaceuticals (AMRX) in Q2 2026: 17,060 shares worth $295K. The stake represents ﹤0.01% of the portfolio and ranks #915 among its holdings. This is a return to the name: Diversified Trust previously reported a position in AMRX as recently as Q1 2022.

Diversified Trust first reported a position in AMRX in Q1 2021 and has held it in 6 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Diversified Trust held 17,060 shares of Amneal Pharmaceuticals worth $295K as of Q2 2026.
  • Amneal Pharmaceuticals was a new Diversified Trust position in Q2 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Diversified Trust's portfolio in Q2 2026, its #915 holding.
  • Diversified Trust first reported a position in Amneal Pharmaceuticals in Q1 2021 and has held it in 6 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.